Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Vascular Stent Market Set To Climb From $19.11 Billion In 2026 To $28.21 Billion By 2030
The vascular stent market has witnessed substantial expansion in recent years. Its value is expected to rise from $17.25 billion in 2025 to $19.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. Historically, this market growth has stemmed from factors including a higher occurrence of cardiovascular diseases, the expansion of catheterization laboratories, increased acceptance of angioplasty procedures, an aging global population, and better access to interventional cardiology treatments.
The vascular stent market is anticipated to experience substantial growth over the next few years. It is projected to reach a value of $28.21 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. This expected growth during the forecast period is driven by factors such as a rising demand for cutting-edge stent technologies, a stronger emphasis on personalized cardiovascular treatments, the expansion of minimally invasive cardiac care options, increasing investments in advanced biomaterials, and the growing adoption of digital imaging-guided interventions. Significant trends observed in this period include the wider acceptance of drug-eluting and bioresorbable stents, an escalating demand for minimally invasive vascular procedures, the increased application of advanced alloy and polymer materials, the broadening scope of peripheral vascular interventions, and an intensified focus on preventing long-term restenosis.
Get A Free Sample Report With In-Depth Market Insights:
Vascular Stent Market Growth Momentum: What Factors Are Shaping Demand?
Rising healthcare spending is anticipated to boost the expansion of the vascular stent market. Healthcare expenditure defines the overall financial outlay by a nation, entity, or person on health-related products and services over a given timeframe. Enhanced healthcare investment facilitates superior infrastructure, upgraded medical facilities, and heightened public knowledge, all contributing positively to the detection and management of vascular ailments. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Consequently, the growing healthcare expenditure is propelling the vascular stent market ahead.
Vascular Stent Market Segment Analysis: What Are The Core Market Categories?
The vascular stent market covered in this report is segmented –
1) By Product: Coronary Stents, Peripheral Vascular Stents
2) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel
3) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent
4) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital
Subsegments:
1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents
2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents
Vascular Stent Market Trends Redefining Industry Growth
Leading corporations are strategically forming alliances and engaging in collaborations with nascent and mid-sized enterprises in the vascular stent market, with the aim of broadening their product and service offerings. These strategic collaborations and partnership agreements enable companies to expand their existing product portfolios and extend their geographical reach. For instance, in September 2023, The Electrospinning Company, a UK-based manufacturer of advanced biomaterials for use in implantable tissue-regenerative devices, partnered with Relisys Medical Devices, an India-based manufacturer of highly innovative cardiovascular medical devices, to develop innovative products that could advance cardiovascular care and revolutionize patient outcomes. This partnership leverages Electrospinning Company’s Caladrix technology to deposit a thin, functional polymer coating without the need for sutures, allowing vascular stents to be manufactured with improved production rates and yields while maintaining efficacy.
Vascular Stent Market Key Participants And Competitive Landscape
Major companies operating in the vascular stent market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Cook Medical, W. L. Gore & Associates, Meril Life Sciences, Sahajanand Medical Technologies, Translumina, Lepu Medical Technology, Stentys, Endologix, JOTEC, Hexacath, iVascular, Balton, Opto Circuits
View The Full Vascular Stent Market Report:
Vascular Stent Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the vascular stent market share in 2025. The regions covered in the vascular stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
